MARK EDWARD ANDERSON, MD PHD
Osteopathic Medicine at Hawkins Dr, Iowa City, IA

License number

Iowa 36520

Professional information

See more information about MARK EDWARD ANDERSON at trustoria.com

Digital Initiatives Librarian At University Of Iowa

Position:

Digital Initiatives Librarian at University of Iowa

Location:

Iowa City, Iowa Area

Industry:

Libraries

Work:

University of Iowa since Jan 2006 - Digital Initiatives Librarian St. Ambrose University May 2004 - Nov 2004 - Digital Images Cataloger for the Father Catich Digital Collection

Education:

University of Iowa 2002 - 2004
MA, Library and Information Science Iowa State University 1998 - 2002
BA, Music

Interests:

digital libraries, history, bicycling

Dr. Mark E Anderson, Iowa City IA - MD (Doctor of Medicine)

Specialties:

Cardiology, Clinical Cardiac Electrophysiology

Address:

UI Hospitals and Clinics
200 Hawkins Dr, Iowa City 52242
(319) 384-8442 (Phone), (319) 384-7345 (Fax)

Certifications:

Cardiovascular Disease, 1995, Clinical Cardiac Electrophysiology, 1996, Internal Medicine, 2005

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

UI Hospitals and Clinics
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242

Education:

Medical School
University of Mn Med Sch
Graduated: 1989

Mark Edward Anderson, Iowa City IA

Specialties:

Internal Medicine, Clinical Cardiac Electrophysiology, Cardiovascular Disease, Cardiac Electrophysiology

Work:

University of Iowa
200 Hawkins Dr, Iowa City, IA 52243

Education:

University of Minnesota, Twin Cities (1989)

Business Manager Vaughn Automotive

Position:

Sales Manager at Deery Brothers Chevrolet

Location:

Iowa City, Iowa Area

Industry:

Automotive

Work:

Deery Brothers Chevrolet - Sales Manager

Mark Edward Anderson, Iowa City IA

Specialties:

Internist

Address:

200 Hawkins Dr, Iowa City, IA 52242

Kits For Detecting Direct Oxidation Of Calcium/Calmodulin Dependent Protein Kinase Ii And Associated Diagnostic And Therapeutic Methods

US Patent:

2013001, Jan 10, 2013

Filed:

Sep 6, 2012

Appl. No.:

13/605341

Inventors:

Mark E. Anderson - Iowa City IA, US
Peter J. Mohler - Iowa City IA, US
Jeffrey Robert Erickson - Utrecht, NL

Assignee:

UNIVERSITY OF IOWA RESEARCH FOUNDATION - Iowa City IA

International Classification:

G01N 33/573, A61P 35/00, A61P 25/28, A61K 31/7088, A61P 9/00

US Classification:

514 44 A, 435 74

Abstract:

Calcium/calmodulin dependent protein kinase II (CaMKII) has been found to be directly oxidized, and direct oxidation of CaMKII was observed to result in calcium independent activation of CaMKII. Antibodies that bind specifically to oxidized forms of CaMKII (oxCaMKII) were generated and were utilized to detect oxCaMKII in blood from: (1) mice with cancer; (2) mice with a knock out of the gene encoding methionine sulfoxide reductase; (3) mice injected with angiotensin II; (4) mice injected with bacterial endotoxin; (5) mice fed a pro-oxidant (ketogenic) diet; and (6) mice with cancer that had been treated with experimental therapy.

Use Of Calmodulin Kinase Ii Inhibitors To Treat Or Prevent Heart Muscle Inflammation

US Patent:

2009027, Nov 5, 2009

Filed:

Apr 30, 2009

Appl. No.:

12/433265

Inventors:

Mark E. Anderson - Iowa City IA, US
Madhu V. Singh - Iowa City IA, US

International Classification:

A61K 38/16, A61K 31/185, A61K 31/496, A61P 9/00

US Classification:

514 12, 514576, 51425305

Abstract:

Provided are compositions and methods of treating inflammation of the heart of a subject diagnosed with inflammation of the heart, comprising administering to the subject an effective amount of an inhibitor of Calmodulin Kinase II, whereby the administration of the inhibitor treats inflammation of the heart in the subject. Also provided are compositions and methods of preventing inflammation of the heart of a subject, comprising administering to the subject an effective amount of an inhibitor of Calmodulin Kinase II, whereby the administration of the inhibitor prevents inflammation of the heart in the subject.

Use Of Calmodulin Kinase Ii Inhibitors To Treat Myocardial Dysfunction In Structural Heart Disease

US Patent:

7320959, Jan 22, 2008

Filed:

Oct 1, 2002

Appl. No.:

10/491323

Inventors:

Mark Anderson - Iowa City IA, US

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A61K 61/00, A01N 25/00

US Classification:

514 12, 514789

Abstract:

The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease.

Methods Of Treating Pulmonary Diseases And Disorders By Modulating Calcium/Calmodulin Dependent Protein Kinase Ii Activity

US Patent:

8440656, May 14, 2013

Filed:

Jun 22, 2010

Appl. No.:

12/820802

Inventors:

Mark E. Anderson - Iowa City IA, US
Isabella M. Grumbach - Iowa City IA, US
Joel N. Kline - Iowa City IA, US

Assignee:

University of Iowa Research Foundation - Iowa City IA

International Classification:

A61K 31/54, A61K 31/44, A61K 31/40, A61K 31/19, A61K 31/195

US Classification:

5142265, 514334, 514420, 514557, 514567

Abstract:

Disclosed are methods of treating or preventing a pulmonary disease or disorder in a subject, the methods comprising administering an effective amount of an compound that inhibits Calmodulin Kinase II (CaMKII) activity, either directly or indirectly, thereby treating or preventing the pulmonary disease or disorder in the subject.